-
-
VITRAKVI
- QTY 50
- 20 MG/ML
- Solution
- Near 77381
LAROTRECTINIB (LAR oh TREK ti nib) treats some types of cancer. It works by blocking a protein that causes cancer cells to grow and multiply. This helps to slow or stop the spread of cancer cells.
Change Location
Set Price Drop Alert for:
VITRAKVI
- QTY 50
- 20 MG/ML
- Solution
What does Supply mean?
If your selected quantity is intended to last longer than one month, please recheck the price using the 3-months supply option. In some cases, the estimated drug price may vary depending on the supply duration.
More Ways to Save On:
VITRAKVI
- QTY 50
- 20 MG/ML
- Solution
You may find alternative ways to save with this medication. Talk to your pharmacist about the potential option(s) noted below.
Change Form
Medicine Chest
VITRAKVI Lifestyle Interactions
-
Larotrectinib 20mg/1mL, Oral solution
• Interaction: Grapefruit juice• Severity: Major• Notes for Consumers: Do not drink grapefruit juice or eat grapefruit while taking this medication. Grapefruit may alter the effects of your medication. Serious side effects may occur. Contact your care team right away if you experience new or worsening side effects.• Notes for Professionals: Advise patients to avoid grapefruit and grapefruit juice during larotrectinib treatment due to the risk for increased larotrectinib exposure and adverse reactions. Larotrectinib is a CYP3A substrate and grapefruit juice is a CYP3A inhibitor.
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment. Drug information is sourced from GSDD (Gold Standard Drug Database ) provided by Elsevier.
